A phase 1, open label study of pharmacokinetic drug interaction between armodafinil and risperidone in healthy volunteers.

Trial Profile

A phase 1, open label study of pharmacokinetic drug interaction between armodafinil and risperidone in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Sep 2015

At a glance

  • Drugs Armodafinil (Primary) ; Risperidone (Primary)
  • Indications Hypersomnia
  • Focus Pharmacokinetics
  • Sponsors Teva Branded Pharmaceutical Products R&D
  • Most Recent Events

    • 23 Sep 2015 New trial record
    • 19 Sep 2015 Results published in the Clinical Drug Investigation.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top